Can others check the field's work or rebuild its results — that is, are data, materials, and code actually shared?
Week 9 distinguishes reproducibility (same data + same analysis → same numbers) from replicability (a new study), and argues that both require the study's data, materials and analysis code to be shared — “as open as possible, as closed as necessary.” The empirical questions are whether the field shares these, whether nominal “availability” translates into actual access, and whether results can therefore be checked.
Sharing is uncommon at every level. Bullock and colleagues (2023), reviewing 243 studies in the top five sports-medicine journals, found only 9% provided open data and 1% shared analysis code, with a median of 2 of 12 open-science practices per study. Schulz and colleagues (2022) found that none of the 163 sports-medicine trials they examined deposited open data, although 74% of those with a data statement said data were “available on request.” Because a result cannot be reproduced — let alone replicated — without its data and code, these rates place a hard limit on the checkability of the field's conclusions.
The gap between stated and actual availability is large and well documented. In a study of biomedical articles with mandatory data-availability statements, Gabelica, Bojčić and Puljak (2022) found that of authors whose statements indicated willingness to share, 93% either did not respond or declined, and among “available on request” authors only 6.8% actually shared data when contacted. Although this evidence is biomedical, it directly undercuts the “on request” model that dominates sport-medicine data statements (Schulz et al., 2022), indicating that nominal availability substantially over-states real access.
These limits are not hypothetical. In reflecting on the field's large replication project, Murphy and colleagues (2025) report that low data sharing and low author response rates hindered replication efforts, with teams struggling to obtain the original data needed to reproduce and replicate studies. The infrastructure to fix this exists — the Open Science Framework and the TOP guidelines (Nosek et al., 2015; Munafò et al., 2017) — and adoption is being called for in the field (Caldwell et al., 2020), but current practice falls well short.
| Source | Finding | Implication |
|---|---|---|
| Bullock et al. (2023) JOSPT | 9% shared open data; 1% shared code; median 2/12 open-science practices | Data and code sharing is rare |
| Schulz et al. (2022) BMJ Open | 0% deposited open data; 74% stated “available on request” | Availability is nominal, not actual |
| Gabelica, Bojčić & Puljak (2022) J. Clin. Epidemiology (adjacent) | 93% did not share despite a willing statement; 6.8% of “on request” shared | “On request” rarely delivers data |
| Murphy et al. (2025) Sports Medicine | Low data sharing and response hindered the field's replication project | The gap blocks reproduction and replication in practice |
| Twomey et al. (2021) Comms. in Kinesiology | Limited trial registration and data accessibility across 300 articles | Corroborates low transparency |
| Nosek et al. (2015); Munafò et al. (2017) Science; Nat. Hum. Behav. (adjacent) | TOP guidelines and reproducibility manifesto define the standards | Infrastructure and standards already exist |
Transparency is the precondition for the self-correction the whole course depends on, and the field currently supplies little of it: open data is shared in under a tenth of studies, code almost never, and the “available on request” model that nominally covers the rest almost never delivers in practice. The direct consequence — the inability to reproduce or replicate published work — has been observed in the field's own replication project. This is a substantial and foundational weakness.
The concern is bounded by two facts. The remedy is well defined and freely available (OSF, TOP guidelines, data-availability standards that require deposit rather than “on request”), and open-access publication is associated with markedly higher sharing, indicating that policy levers work. The problem is one of practice and enforcement, not of missing tools, and is therefore correctable through journal and funder requirements.
Bullock, G. S., Ward, P., Impellizzeri, F. M., et al. (2023). Up front and open? Shrouded in secrecy? Or somewhere in between? A meta-research systematic review of open science practices in sport medicine research. Journal of Orthopaedic & Sports Physical Therapy, 53(12), 735–747. https://doi.org/10.2519/jospt.2023.12016
Caldwell, A. R., Vigotsky, A. D., Tenan, M. S., et al. (2020). Moving sport and exercise science forward: a call for the adoption of more transparent research practices. Sports Medicine, 50(3), 449–459. https://doi.org/10.1007/s40279-019-01227-1
Gabelica, M., Bojčić, R., & Puljak, L. (2022). Many researchers were not compliant with their published data sharing statement: a mixed-methods study. Journal of Clinical Epidemiology, 150, 33–41. https://doi.org/10.1016/j.jclinepi.2022.05.019
Munafò, M. R., Nosek, B. A., Bishop, D. V. M., et al. (2017). A manifesto for reproducible science. Nature Human Behaviour, 1, 0021. https://doi.org/10.1038/s41562-016-0021
Murphy, J., Caldwell, A. R., & Warne, J. P. (2025). Reflections on conducting a large replication project in sports and exercise science. Sports Medicine, 55(10). https://doi.org/10.1007/s40279-025-02200-x
Nosek, B. A., Alter, G., Banks, G. C., et al. (2015). Promoting an open research culture. Science, 348(6242), 1422–1425. https://doi.org/10.1126/science.aab2374
Schulz, R., Langen, G., Prill, R., Cassel, M., & Weissgerber, T. L. (2022). Reporting and transparent research practices in sports medicine and orthopaedic clinical trials: a meta-research study. BMJ Open, 12(8), e059347. https://doi.org/10.1136/bmjopen-2021-059347
Twomey, R., Harlley, S., Romero Medina, C., et al. (2021). The nature of our literature: a registered report on the positive result rate and reporting practices in kinesiology. Communications in Kinesiology, 1(3), article 43. https://doi.org/10.51224/cik.v1i3.43